Inventor
VAN ROOIJ EVA
NL23 patents
⚠️ This page may combine multiple inventors who share the name “VAN ROOIJ EVA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
10 patentsUS8940713B2Jan 27, 2015
Micro-RNA family that modulates fibrosis and uses thereof
UNIV TEXAS6 citations84
US8940712B2Jan 27, 2015
Micro-RNA family that modulates fibrosis and uses thereof
UNIV TEXAS6 citations84
US8940711B2Jan 27, 2015
Micro-RNA family that modulates fibrosis and uses thereof
UNIV TEXAS6 citations84
US9719086B2Aug 1, 2017
Micro-RNA family that modulates fibrosis and uses thereof
UNIV TEXAS2 citations73
US9719087B2Aug 1, 2017
Micro-RNA family that modulates fibrosis and uses thereof
UNIV TEXAS2 citations73
US9719088B2Aug 1, 2017
Micro-RNA family that modulates fibrosis and uses thereof
UNIV TEXAS2 citations73
US8962588B2Feb 24, 2015
Micro-RNAS that control myosin expression and myofiber identity
UNIV TEXAS2 citations63
US9428749B2Aug 30, 2016
Control of whole body energy homeostasis by microRNA regulation
UNIV TEXAS2 citations57
US10392618B2Aug 27, 2019
Micro-RNA family that modulates extracellular matrix genes and uses thereof
UNIV TEXAS0 citations52
US9078919B2Jul 14, 2015
Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair
UNIV TEXAS1 citations52
MIRAGEN THERAPEUTICS INC
6 patentsUS9388408B2Jul 12, 2016
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
MIRAGEN THERAPEUTICS INC9 citations81
US9376681B2Jun 28, 2016
miR-29 mimics and uses thereof
MIRAGEN THERAPEUTICS INC9 citations79
US9803202B2Oct 31, 2017
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
MIRAGEN THERAPEUTICS INC2 citations68
US10337005B2Jul 2, 2019
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
MIRAGEN THERAPEUTICS INC0 citations49
US9994847B2Jun 12, 2018
miR-29 mimics and uses thereof
MIRAGEN THERAPEUTICS INC1 citations47
US9752143B2Sep 5, 2017
Locked nucleic acid inhibitor of miR-145 and uses thereof
MIRAGEN THERAPEUTICS INC0 citations40
OLSON ERIC
4 patentsUS8440636B2May 14, 2013
Micro-RNA family that modulates fibrosis and uses thereof
OLSON ERIC10 citations92
US8629119B2Jan 14, 2014
Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
OLSON ERIC7 citations83
US8481507B2Jul 9, 2013
Micro-RNAs that control myosin expression and myofiber identity
OLSON ERIC10 citations83
US8513209B2Aug 20, 2013
Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair
OLSON ERIC3 citations62